|
|
Blood, 15 September 2007, Vol. 110, No. 6, pp. 1970-1981.
Prepublished online as a Blood First Edition Paper on June 4, 2007; DOI 10.1182/blood-2006-09-044776.
Previous Article | Next Article 
Submitted September 1, 2006
Accepted May 28, 2007
A novel role for HMGB1 in TLR9-mediated inflammatory
responses to CpG-DNA
Stanimir Ivanov, Ana-Maria Dragoi, Xin Wang, Corrado Dallacosta, Jennifer Louten, Giovanna Musco, Giovanni Sitia, George S. Yap, Yinsheng Wan, Christine A Biron, Marco E Bianchi, Haichao Wang, and Wen-Ming Chu*
Department of Molecular Microbiology and Immunology, Brown University, Providence, RI, United States
San Raffaele Scientific Institute, Milano, Italy
Department of Biology, Providence College, Providence, RI, United States
Faculty of Medicine, San Raffaele University, Milano, Italy
Department of Emergency Medicine, North Shore-Long Island Jewish Research Institute, Manhasset, NY, United States
* Corresponding author; email: wen-ming_chu{at}brown.edu.
CpG-DNA or its synthetic analogue CpG-ODN activates innate immunity through Toll-like receptor 9 (TLR9). However, the mechanism of TLR9 activation by CpG-DNA remains elusive. Here we have identified HMGB1 as a CpG-ODN binding protein. HMGB1 interacts and pre-associates with TLR9 in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC), and hastens its redistribution to early endosomes in response to CpG-ODN. CpG-ODN stimulates macrophages and dendritic cells to secrete HMGB1; in turn, extracellular HMGB1 accelerates the delivery of CpG-ODNs to its receptor leading to a TLR9-dependent augmentation of IL-6, IL-12, and TNF secretion. Loss of HMGB1 leads to a defect in IL-6, IL-12, TNF , and iNOS response to CpG-ODN. However, the lack of intracellular TLR9-associated HMGB1 can be compensated by extracellular HMGB1. Thus, the DNA-binding protein HMGB1 shuttles in and out of immune cells and regulates inflammatory responses to CpG-DNA.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Tang, R. Kang, W. Xiao, H. Zhang, M. T. Lotze, H. Wang, and X. Xiao
Quercetin Prevents LPS-Induced High-Mobility Group Box 1 Release and Proinflammatory Function
Am. J. Respir. Cell Mol. Biol.,
December 1, 2009;
41(6):
651 - 660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Qin, S.-M. Dai, G.-S. Tang, J. Zhang, D. Ren, Z.-W. Wang, and Q. Shen
HMGB1 Enhances the Proinflammatory Activity of Lipopolysaccharide by Promoting the Phosphorylation of MAPK p38 through Receptor for Advanced Glycation End Products
J. Immunol.,
November 15, 2009;
183(10):
6244 - 6250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Palumbo, F. De Marchis, T. Pusterla, A. Conti, M. Alessio, and M. E. Bianchi
Src family kinases are necessary for cell migration induced by extracellular HMGB1
J. Leukoc. Biol.,
September 1, 2009;
86(3):
617 - 623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Hreggvidsdottir, T. Ostberg, H. Wahamaa, H. Schierbeck, A.-C. Aveberger, L. Klevenvall, K. Palmblad, L. Ottosson, U. Andersson, and H. E. Harris
The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation
J. Leukoc. Biol.,
September 1, 2009;
86(3):
655 - 662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yao, X. Liu, D. Li, T. Chen, Z. Cai, and X. Cao
Late Endosome/Lysosome-Localized Rab7b Suppresses TLR9-Initiated Proinflammatory Cytokine and Type I IFN Production in Macrophages
J. Immunol.,
August 1, 2009;
183(3):
1751 - 1758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Urbonaviciute, B. G. Furnrohr, S. Meister, L. Munoz, P. Heyder, F. De Marchis, M. E. Bianchi, C. Kirschning, H. Wagner, A. A. Manfredi, et al.
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE
J. Exp. Med.,
December 22, 2008;
205(13):
3007 - 3018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. B. Uccellini, L. Busconi, N. M. Green, P. Busto, S. R. Christensen, M. J. Shlomchik, A. Marshak-Rothstein, and G. A. Viglianti
Autoreactive B Cells Discriminate CpG-Rich and CpG-Poor DNA and This Response Is Modulated by IFN-{alpha}
J. Immunol.,
November 1, 2008;
181(9):
5875 - 5884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Re and J. L. Cook
The physiological basis of intracrine stem cell regulation
Am J Physiol Heart Circ Physiol,
August 1, 2008;
295(2):
H447 - H453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chorny, P. Anderson, E. Gonzalez-Rey, and M. Delgado
Ghrelin Protects against Experimental Sepsis by Inhibiting High-Mobility Group Box 1 Release and by Killing Bacteria
J. Immunol.,
June 15, 2008;
180(12):
8369 - 8377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Youn, Y. J. Oh, E. S. Kim, J. E. Choi, and J.-S. Shin
High Mobility Group Box 1 Protein Binding to Lipopolysaccharide Facilitates Transfer of Lipopolysaccharide to CD14 and Enhances Lipopolysaccharide-Mediated TNF-{alpha} Production in Human Monocytes
J. Immunol.,
April 1, 2008;
180(7):
5067 - 5074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. Re and J. L. Cook
The Basis of an Intracrine Pharmacology
J. Clin. Pharmacol.,
March 1, 2008;
48(3):
344 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|